Inicio > Neumología > Mortalidad por cáncer del pulmón > Página 3

Mortalidad por cáncer del pulmón

Referencias bibliográficas

  1. Varona P, Herrera D, García R, Bonet M, Romero T, Venero S. Smoking-AttributableMortality in Cuba. MEDICC Review [Internet]. 2009 [citedmay 201011(3):43-7. Disponible en: http://www.medicc.org/mediccreview/articles/mr_105.pdf
  2. Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y estadísticas de Salud. Anuario Estadístico de Salud. La Habana: MINSAP; 2010.
  3. Instituto Nacional del Cáncer. Lo que usted necesita saber sobre el cáncer de pulmón [Internet]. Rockville, MD: NCI; 2008 [citado: mayo 2010]. Disponible en: http://www.cancer.gov/espanol/tipos/necesita-saber/pulmon.pdf
  4. Doll R, Petto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ [Internet]. 2004 [cited may 2010] 328(7455):1519-28. Disponible en: http://www.bmj.com/content/328/7455/1519.long
  5. UU. Department of Health and Human Services. How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the surgeon general [Internet]. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. Office of the Surgeon General [Internet]. 2010 [cited: may 2010]. Disponible en:http://www.surgeongeneral.gov/library/tobaccosmoke/report/executivesummary.pdf
  6. Fiore M, Bailey W, Cohen S, Dorfman S, Goldstein M, Gritz E, et al. Treating tobacco use and dependence [Internet]. Rockville (MD): EE.UU. Department of Health and Human Services, Public Health Service; 2008 [cited may 2010]. Disponible en: http://www.guideline.gov/content.aspx?id=12520
  7. The Royal Australian Collage of General Practitioners. Guidelines for Preventive Activities in General Practice (the red book) [Internet]. Melbourne: RACGP; 2009 [cited may 2010]. Available from: http://www.racgp.org.au/guidelines/redbook
  8. Galán Y, et al. Trends in Cuba’s Cancer Incidence (1990 to 2003) and Mortality (1990 to 2007). MEDICC Review. Summer 2009;11(3).
  9. Anuario Estadístico de Salud en Cuba. Disponible en: http://bvs.sld.cu/anuario.
  10. García B, Neninger E, de la Torre A et al. Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti-Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non-Small-Cell Lung Cancer Patients Treated with the Epidermal Growth Factor Cancer Vaccine. ClinCancer Res. 2008;14(3). Disponible en: http://www.aacrjournals.org
  11. Neninger E, Osorio M, Catala M, de la Torre A, Acosta Z, Rives R, Viada C, Garcia B, Crombet T, Gonzalez G, Lage A. Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced Non–Small-Cell Lung Cancer. J ClinOncol. 2008;26:1452-1458.
  12. Gorlova OY, FengWeng S, Zhang Y, Amos CI, Spitz MR. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007;121:111-118.
  13. Bach P, Silvestre G, Hanger M, Jett J. Screening for lung cancer: ACCP Evidence-Based Clinical practice Guidelines. Chest [Internet]. 2007 [cited may 2010] 132(3 Suppl.):S69-77. Disponible en: http://chestjournal.chestpubs.org/content/132/3_suppl/69S.long
  14. Black C, Verteuil R, Walker Sh, Ayres J, Boland A, Bagust A, Waugh N. Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature. Thorax [Internet]. 2007 [cited may 2010] 62(2):131-8. Disponible en: http://thorax.bmj.com/content/62/2/131.full.pdf
  15. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM: CYP1A1 Ile462 and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis. 2005; Sep 29.
Páginas: 1 2 3